[Federal Register Volume 83, Number 199 (Monday, October 15, 2018)]
[Notices]
[Pages 51983-51984]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-22415]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Specgx, 
LLC

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written

[[Page 51984]]

comments on or objections to the issuance of the proposed registration 
on or before December 14, 2018.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on July 
26, 2018, Specgx, LLC, 3600 North Second Street, Saint Louis, Missouri 
63147-3457 applied to be registered as a bulk manufacturer of the 
following basic class of controlled substance:

------------------------------------------------------------------------
           Controlled substance               Drug code       Schedule
------------------------------------------------------------------------
Fentanyl-related substances, their                   9850  I
 isomers, esters, ethers, salts and salts
 of isomers, esters, and ethers.
------------------------------------------------------------------------

    The company plans to manufacture the above-listed controlled 
substance in gram quantities for sale as analytical research standards.

    Dated: September 24, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-22415 Filed 10-12-18; 8:45 am]
BILLING CODE 4410-09-P